Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.04 USD | +1.57% | +0.11% | -2.80% |
Financials (USD)
Sales 2024 * | 2.05B | Sales 2025 * | 2.11B | Capitalization | 747M |
---|---|---|---|---|---|
Net income 2024 * | 86M | Net income 2025 * | 89M | EV / Sales 2024 * | 0.59 x |
Net Debt 2024 * | 452M | Net Debt 2025 * | 387M | EV / Sales 2025 * | 0.54 x |
P/E ratio 2024 * |
8.49
x | P/E ratio 2025 * |
8.26
x | Employees | 5,450 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.62% |
Latest transcript on Pediatrix Medical Group, Inc.
1 day | +1.57% | ||
1 week | +0.11% | ||
Current month | -9.87% | ||
1 month | -5.74% | ||
3 months | -8.32% | ||
6 months | -22.27% | ||
Current year | -2.80% |
Managers | Title | Age | Since |
---|---|---|---|
James Swift
CEO | Chief Executive Officer | - | 08-12-31 |
C. Richards
DFI | Director of Finance/CFO | 54 | 20-09-07 |
Mark Ordan
CHM | Chairman | 65 | 20-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Ordan
CHM | Chairman | 65 | 20-07-11 |
Guy Sansone
BRD | Director/Board Member | 59 | 20-07-11 |
Thomas McEachin
BRD | Director/Board Member | 71 | 20-07-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 45 M€ | +0.20% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.04 | +1.57% | 650,180 |
24-04-25 | 8.9 | -3.68% | 424,742 |
24-04-24 | 9.24 | -1.70% | 472,481 |
24-04-23 | 9.4 | +4.10% | 500,333 |
24-04-22 | 9.03 | 0.00% | 506,578 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.80% | 747M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-3.97% | 11.66B | |
-1.42% | 11.72B | |
-31.75% | 11.77B |
- Stock Market
- Equities
- MD Stock